These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23519216)

  • 101. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report.
    Rovasalo A; Tohmo H; Aantaa R; Kettunen E; Palojoki R
    Gen Hosp Psychiatry; 2006; 28(4):362-3. PubMed ID: 16814639
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.
    Wang X; Chen Y; Zhou X; Liu F; Zhang T; Zhang C
    J ECT; 2012 Jun; 28(2):128-32. PubMed ID: 22622291
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Dexmedetomidine overdose in the perioperative setting.
    Jorden VS; Pousman RM; Sanford MM; Thorborg PA; Hutchens MP
    Ann Pharmacother; 2004 May; 38(5):803-7. PubMed ID: 15039474
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Predictors of electroconvulsive therapy postictal delirium.
    Reti IM; Krishnan A; Podlisky A; Sharp A; Walker M; Neufeld KJ; Hayat MJ
    Psychosomatics; 2014; 55(3):272-9. PubMed ID: 23871331
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comments on "Postanesthesia Recovery Unit Optimization for Patients With Postictal Agitation Secondary to Electroconvulsive Therapy" by Arora et al.
    Beilstein CM; Meyer A; Lehmann LE; Wuethrich PY
    J ECT; 2023 Dec; 39(4):274-275. PubMed ID: 38009971
    [No Abstract]   [Full Text] [Related]  

  • 106. An updated focused review of dexmedetomidine in adults.
    Gerlach AT; Murphy CV; Dasta JF
    Ann Pharmacother; 2009 Dec; 43(12):2064-74. PubMed ID: 19934395
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Successful treatment of ifosfamide neurotoxicity with dexmedetomidine.
    Bernard PA; McCabe T; Bayliff S; Hayes D
    J Oncol Pharm Pract; 2010 Dec; 16(4):262-5. PubMed ID: 20118215
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy.
    Tokutsu Y; Umene-Nakano W; Yoshimura R; Katsuki A; Atake K; Nakamura J
    J ECT; 2012 Mar; 28(1):56. PubMed ID: 21778911
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Electroconvulsive therapy for agitation in Alzheimer disease: a case series.
    Sutor B; Rasmussen KG
    J ECT; 2008 Sep; 24(3):239-41. PubMed ID: 18562945
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Dexmedetomidine (Precedex) for ICU sedation.
    Med Lett Drugs Ther; 2011 May; 53(1365):41-2. PubMed ID: 21617592
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Use of continuation or maintenance electroconvulsive therapy in adolescents with severe treatment-resistant depression.
    Ghaziuddin N; Dumas S; Hodges E
    J ECT; 2011 Jun; 27(2):168-74. PubMed ID: 21233763
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Dexmedetomidine in a child with methylphenidate intoxication.
    Bagdure DN; Bhoite GR; Reiter PD; Dobyns EL
    Indian J Pediatr; 2013 Apr; 80(4):343-4. PubMed ID: 22562228
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Dexmedetomidine to facilitate drug withdrawal.
    Maccioli GA
    Anesthesiology; 2003 Feb; 98(2):575-7. PubMed ID: 12552220
    [No Abstract]   [Full Text] [Related]  

  • 114. Takotsubo cardiomyopathy following electroconvulsive therapy: an increasingly recognised phenomenon.
    Narayanan A; Russell MD; Sundararaman S; Shankar KK; Artman B
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25425252
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Post-ECT agitation and plasma lactate concentrations.
    Auriacombe M; Rénéric JP; Usandizaga D; Gomez F; Combourieu I; Tignol J
    J ECT; 2000 Sep; 16(3):263-7. PubMed ID: 11005048
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Dexmedetomidine for the management of postictal agitation after electroconvulsive therapy with S-ketamine anesthesia.
    Aksay SS; Bumb JM; Remennik D; Thiel M; Kranaster L; Sartorius A; Janke C
    Neuropsychiatr Dis Treat; 2017; 13():1389-1394. PubMed ID: 28579785
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Topiramate for post-electroconvulsive therapy headaches.
    Ye L; Karlapati SK; Lippmann S
    J ECT; 2013 Sep; 29(3):e49. PubMed ID: 23965610
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Promethazine for the treatment of agitation after electroconvulsive therapy: a case series.
    Vishne T; Amiaz R; Grunhaus L
    J ECT; 2005 Jun; 21(2):118-21. PubMed ID: 15905755
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Dexmedetomidine is a useful adjunct for awake intubation.
    Maroof M; Khan RM; Jain D; Ashraf M
    Can J Anaesth; 2005; 52(7):776-7. PubMed ID: 16103401
    [No Abstract]   [Full Text] [Related]  

  • 120. Alpha-2 agonists as first-line sedative agents in hyperammonemia-induced hyperexcitability?
    Pichot C; Ghignone M; Quintin L
    Paediatr Anaesth; 2013 Sep; 23(9):878-80. PubMed ID: 23927527
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.